 |
Basal cell carcinomas can recur in some patients, and subsequent treatment can be difficult.1-3 When the BCC advances and you're running out of treatment options... WHAT'S NEXT FOR THESE PATIENTS? |
|||||
 |
||||||
|
 |
|
||
|
|
Genentech is investigating the molecular basis of skin cancers such as advanced BCC. References: 1. Rowe DE. Comparison of treatment modalities for basal cell carcinoma. Clin Dermatol. 1995;13:617-620. 2. Chew R. Destruction of the orbit and globe by recurrence of basal cell carcinoma. Optometry. 2007;78:344-351. 3. Robinson JK, Fisher SG. Recurrent basal cell carcinoma after incomplete resection. Arch Dermatol. 2000;136:1318-1324. Privacy Policy | Terms and Conditions | Contact Genentech® This e-mail is intended for U.S. healthcare professionals only. Genentech USA, Inc. 1 DNA Way South San Francisco, CA 94080-4990 © 2011 Genentech USA, Inc. All rights reserved. To unsubscribe from the Genentech mailing list, please click here. HED0000567700 |
|
|
 |
||||